| Literature DB >> 29215724 |
Patrick O Azevedo1, Isadora F G Sena1, Julia P Andreotti1, Juliana Carvalho-Tavares2, José C Alves-Filho3, Thiago M Cunha3, Fernando Q Cunha3, Akiva Mintz4, Alexander Birbrair1,4.
Abstract
Multiple sclerosis is a highly prevalent chronic demyelinating disease of the central nervous system. Remyelination is the major therapeutic goal for this disorder. The lack of detailed knowledge about the cellular and molecular mechanisms involved in myelination restricts the design of effective treatments. A recent study by using [De La Fuente et al. (2017) Cell Reports, 20(8): 1755-1764] by using state-of-the-art techniques, including pericyte-deficient mice in combination with induced demyelination, reveal that pericytes participate in central nervous system regeneration. Strikingly, pericytes presence is essential for oligodendrocyte progenitors differentiation and myelin formation during remyelination in the brain. The emerging knowledge from this research will be important for the treatment of multiple sclerosis.Entities:
Keywords: central nervous system; multiple sclerosis; myelination; pericytes
Mesh:
Year: 2018 PMID: 29215724 PMCID: PMC6076852 DOI: 10.1002/jcp.26348
Source DB: PubMed Journal: J Cell Physiol ISSN: 0021-9541 Impact factor: 6.384